Global Premenstrual Syndrome Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Premenstrual Syndrome Treatment market size was valued at US$ 1486 million in 2025 and is forecast to a readjusted size of US$ 1863 million by 2032 with a CAGR of 3.3% during review period.
Premenstrual syndrome or PMS is a group of physical and emotional symptoms many women may have in the days before their period starts. Symptoms usually stop once the period starts. It’s thought to be related to the changing hormone levels of the menstrual cycle.Lifestyle changes and sometimes medicine are used to treat PMS.
The global premenstrual syndrome (PMS) treatment market refers to the market for various products and therapies aimed at managing the symptoms associated with PMS. PMS refers to a combination of physical, emotional, and behavioral symptoms experienced by women in the days leading up to their menstrual period.
The market for PMS treatment is influenced by the growing awareness and recognition of PMS as a medical condition, the increasing number of women seeking medical assistance for PMS symptoms, and the development of new treatment options. Here are some key factors and trends in the global PMS treatment market:
Product Types: The PMS treatment market offers a range of products, including medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives, antidepressants, and diuretics. Alternative therapies like herbal remedies, nutritional supplements, and lifestyle modifications are also popular.
Hormonal Contraceptives: Hormonal contraceptives, such as oral contraceptives and intrauterine devices (IUDs), are commonly prescribed for managing PMS symptoms. These contraceptives help regulate hormone levels and reduce symptoms like mood swings, pain, and bloating.
Antidepressants: Certain antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), are often prescribed to alleviate the emotional symptoms associated with PMS, including irritability, depression, and anxiety.
Herbal Remedies and Nutritional Supplements: There is a growing demand for natural and holistic approaches to managing PMS symptoms. Herbal remedies like chasteberry, evening primrose oil, and black cohosh, as well as nutritional supplements like calcium, magnesium, and vitamin B6, are commonly used for symptom relief.
Awareness and Education: Increasing efforts to raise awareness about PMS and its impact on women’s health are leading to improved recognition and diagnosis of the condition. This awareness is driving the demand for effective treatment options and encouraging more women to seek medical help.
Online Platforms and Apps: The availability of online platforms and mobile applications focused on women’s health is helping to educate and empower women in managing their PMS symptoms. These platforms provide information, symptom tracking tools, and community support.
Research and Development: The PMS treatment market is witnessing ongoing research and development activities to explore new treatment options, including innovative drug therapies, herbal formulations, and personalized medicine approaches.
Regional Market: The PMS treatment market varies across regions due to differences in healthcare infrastructure, cultural beliefs, and access to medical services. North America and Europe are expected to dominate the global market due to higher awareness and healthcare expenditure, while Asia Pacific is projected to exhibit significant growth due to rising healthcare awareness and improving access to healthcare.The global premenstrual syndrome (PMS) treatment market refers to the market for various products and therapies aimed at managing the symptoms associated with PMS. PMS refers to a combination of physical, emotional, and behavioral symptoms experienced by women in the days leading up to their menstrual period.
The market for PMS treatment is influenced by the growing awareness and recognition of PMS as a medical condition, the increasing number of women seeking medical assistance for PMS symptoms, and the development of new treatment options. Here are some key factors and trends in the global PMS treatment market:
Product Types: The PMS treatment market offers a range of products, including medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives, antidepressants, and diuretics. Alternative therapies like herbal remedies, nutritional supplements, and lifestyle modifications are also popular.
Hormonal Contraceptives: Hormonal contraceptives, such as oral contraceptives and intrauterine devices (IUDs), are commonly prescribed for managing PMS symptoms. These contraceptives help regulate hormone levels and reduce symptoms like mood swings, pain, and bloating.
Antidepressants: Certain antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), are often prescribed to alleviate the emotional symptoms associated with PMS, including irritability, depression, and anxiety.
Herbal Remedies and Nutritional Supplements: There is a growing demand for natural and holistic approaches to managing PMS symptoms. Herbal remedies like chasteberry, evening primrose oil, and black cohosh, as well as nutritional supplements like calcium, magnesium, and vitamin B6, are commonly used for symptom relief.
Awareness and Education: Increasing efforts to raise awareness about PMS and its impact on women’s health are leading to improved recognition and diagnosis of the condition. This awareness is driving the demand for effective treatment options and encouraging more women to seek medical help.
Online Platforms and Apps: The availability of online platforms and mobile applications focused on women’s health is helping to educate and empower women in managing their PMS symptoms. These platforms provide information, symptom tracking tools, and community support.
Research and Development: The PMS treatment market is witnessing ongoing research and development activities to explore new treatment options, including innovative drug therapies, herbal formulations, and personalized medicine approaches.
Regional Market: The PMS treatment market varies across regions due to differences in healthcare infrastructure, cultural beliefs, and access to medical services. North America and Europe are expected to dominate the global market due to higher awareness and healthcare expenditure, while Asia Pacific is projected to exhibit significant growth due to rising healthcare awareness and improving access to healthcare.
This report is a detailed and comprehensive analysis for global Premenstrual Syndrome Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Premenstrual Syndrome Treatment market size and forecasts, in consumption value ($ Million), 2021-2032
Global Premenstrual Syndrome Treatment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Premenstrual Syndrome Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Premenstrual Syndrome Treatment market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Premenstrual Syndrome Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Premenstrual Syndrome Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, AstraZeneca, BASF Corporation, Bayer, Eli Lilly And Company, GlaxoSmithKline, Pfizer, Shionogi, Johnson & Johnson, Novartis AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Premenstrual Syndrome Treatment market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Medication
Dietary Treatment
Emotional Treatment
Hormone Therapy
Others
Market segment by Application
Younger than 20 Years
20-40 Years Old Adults
Market segment by players, this report covers
AbbVie
AstraZeneca
BASF Corporation
Bayer
Eli Lilly And Company
GlaxoSmithKline
Pfizer
Shionogi
Johnson & Johnson
Novartis AG
Merck & Co., Inc.
Allergan plc
Mylan N.V.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Premenstrual Syndrome Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Premenstrual Syndrome Treatment, with revenue, gross margin, and global market share of Premenstrual Syndrome Treatment from 2021 to 2026.
Chapter 3, the Premenstrual Syndrome Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Premenstrual Syndrome Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Premenstrual Syndrome Treatment.
Chapter 13, to describe Premenstrual Syndrome Treatment research findings and conclusion.